Guerrero Ramiro 4
4 · MAIA Biotechnology, Inc. · Filed Nov 4, 2024
Insider Transaction Report
Form 4
Guerrero Ramiro
Director
Transactions
- Purchase
Common Stock
2024-11-01$2.51/sh+88,534$222,220→ 408,134.04 total - Purchase
Warrants
2024-11-01$2.26/sh+88,534$199,998→ 88,534 totalExercise: $2.26From: 2025-05-01Exp: 2030-05-01→ Common Stock (88,534 underlying)
Footnotes (2)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024.
- [F2]These warrants were purchased pursuant to a Securities Purchase Agreement dated and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.